State by State Market Insights
SERVICES
We have ore than 50 years of experience
Tilt phone to view map
Blinking indicates recent activity
-States that are not clickable have no meaningful activity.
DC
.svg){kind=small}
District of Colombia Snapshot
Notable Players
Population
~0.7MM
Medicinal Legalization
1998
First Adult-Use Sale
Pending
MMJ Patients
11K
Monthly Revenue
~$5MM
Cultivation Licenses
8/10 (Operational/Limit)
Retail Licenses
7/8 (Operational/Limit)
Updated on May 17, 2022
ME
Maine Snapshot
Notable Players
Population
~1.4MM
Medicinal Legalization
1999
First Adult-Use Sale
2020
MMJ Patients
~77K
Monthly Revenue
~$11MM
Cultivation Licenses
67/No Limit (Operational/Limit)
Retail Licenses
85/No Limit (Operational/Limit)
Updated on May 16, 2022
VT
Vermont Snapshot
Notable Players
Population
~0.7MM
Medicinal Legalization
2004
First Adult-Use Sale
Pending
MMJ Patients
~6K
Monthly Revenue
~$2MM
Cultivation Licenses
5/No Limit (Operational/Limit)*
Retail Licenses
6/No Limit (Operational/Limit)*
Updated on May 17, 2022
NH
New Hampshire Snapshot
Notable Players
Population
~1.4MM
Medicinal Legalization
2013
First Adult-Use Sale
N/A
MMJ Patients
~14K
Monthly Revenue
~$3.5MM
Cultivation Licenses
3/4 (Operational/Limit)*
Retail Licenses
7/7 (Operational/Limit)*
Updated on May 17, 2022
MA
Massachusetts Snapshot
Notable Players
Population
~6.9MM
Medicinal Legalization
2012
First Adult-Use Sale
2018
MMJ Patients
~100K
Monthly Revenue
~$154MM
Cultivation Licenses
121/No Limit (Operational/Limit)
Retail Licenses
222/No Limit (Operational/Limit)
Updated on May 16, 2022
RI
Rhode Island Snapshot
Notable Players
Population
~1.1MM
Medicinal Legalization
2005
First Adult-Use Sale
N/A
MMJ Patients
~22K
Monthly Revenue
~$6MM
Cultivation Licenses
68/No Limit (Operational/Limit)
Retail Licenses
3/9 (Operational/Limit)
Updated on May 17, 2022
CT
Connecticut Snapshot
Notable Players
Population
~3.6MM
Medicinal Legalization
2012
First Adult-Use Sale
Pending
MMJ Patients
~60K
Monthly Revenue
~$15MM
Cultivation Licenses
4/10 (Operational/Limit)
Retail Licenses
17/18 (Operational/Limit)
Updated on May 17, 2022
NY
New York Snapshot
Notable Players
Population
~19.4MM
Medicinal Legalization
2014
First Adult-Use Sale
Pending
MMJ Patients
~151K
Monthly Revenue
~$23MM
Cultivation Licenses
11/11 (Operational/Limit)*
Retail Licenses
38/38 (Operational/Limit)*
Updated on May 17, 2022
NJ
New Jersey Snapshot
Notable Players
Population
~8.9MM
Medicinal Legalization
2010
First Adult-Use Sale
Pending
MMJ Patients
~125K
Monthly Revenue
~$20MM
Cultivation Licenses
44/37 (Operational/Limit)*
Retail Licenses
24/53 (Operational/Limit)*
Updated on May 17, 2022
DE
Delaware Snapshot
Notable Players
Population
~3.6MM
Medicinal Legalization
2011
First Adult-Use Sale
N/A
MMJ Patients
~20K
Monthly Revenue
~$5MM
Cultivation Licenses
4/No Limit (Operational/Limit)
Retail Licenses
7/No Limit (Operational/Limit)
Updated on May 17, 2022
MD
Maryland Snapshot
Notable Players
Population
~6.1MM
Medicinal Legalization
2014
First Adult-Use Sale
N/A
MMJ Patients
~147K
Monthly Revenue
~$46MM
Cultivation Licenses
18/21 (Operational/Limit)
Retail Licenses
97/102 (Operational/Limit)
Updated on May 17, 2022
PA
Pennsylvania Snapshot
Notable Players
Population
~12.8MM
Medicinal Legalization
2016
First Adult-Use Sale
N/A
MMJ Patients
~575K
Monthly Revenue
~$133MM
Cultivation Licenses
33/33 (Operational/Limit)
Retail Licenses
157/157 (Operational/Limit)*
Updated on May 17, 2022
WV
West Virginia Snapshot
Notable Players
Population
~1.8MM
Medicinal Legalization
2017
First Adult-Use Sale
N/A
MMJ Patients
~6K
Monthly Revenue
~$1MM
Cultivation Licenses
10/10 (Operational/Limit)
Retail Licenses
8/100 (Operational/Limit)
Updated on May 17, 2022
VA
Virginia Snapshot
Notable Players
Population
~8.6MM
Medicinal Legalization
2018
First Adult-Use Sale
Pending
MMJ Patients
~34K
Monthly Revenue
~$2MM
Cultivation Licenses
4/5 (Operational/Limit)*
Retail Licenses
10/30 (Operational/Limit)*
Updated on May 17, 2022
NC
North Carolina Snapshot
Notable Players
Population
~10.5MM
Medicinal Legalization
N/A
First Adult-Use Sale
N/A
MMJ Patients
N/A
Monthly Revenue
N/A
Cultivation Licenses
N/A
Retail Licenses
N/A
Updated on May 17, 2022
SC
South Carolina Snapshot
Notable Players
Population
~5MM
Medicinal Legalization
N/A
First Adult-Use Sale
N/A
MMJ Patients
N/A
Monthly Revenue
N/A
Cultivation Licenses
N/A
Retail Licenses
N/A
Updated on May 17, 2022
FL
Florida Snapshot
Notable Players
Population
~21.9MM
Medicinal Legalization
2014
First Adult-Use Sale
N/A
MMJ Patients
~600K
Monthly Revenue
~$193MM
Cultivation Licenses
22/22 (Operational/Limit)*
Retail Licenses
440/22 (Operational/Limit)*
Updated on May 17, 2022
GA
Georgia Snapshot
Notable Players
Population
~10.8MM
Medicinal Legalization
2015
First Adult-Use Sale
N/A
MMJ Patients
~15K
Monthly Revenue
0
Cultivation Licenses
0/6 (Operational/Limit)
Retail Licenses
0/30 (Operational/Limit)
Updated on May 17, 2022
MS
Mississippi Snapshot
Notable Players
Population
~3MM
Medicinal Legalization
N/A
First Adult-Use Sale
N/A
MMJ Patients
0
Monthly Revenue
0
Cultivation Licenses
0 (Operational/Limit)
Retail Licenses
0 (Operational/Limit)
Updated on May 17, 2022
AL
Alabama Snapshot
Notable Players
Population
~5.03MM
Medicinal Legalization
2021
First Adult-Use Sale
N/A
MMJ Patients
N/A
Monthly Revenue
N/A
Cultivation Licenses
0/4 (Operational/Limit)
Retail Licenses
0/4 (Operational/Limit)
Updated on May 17, 2022
KY
Kentucky Snapshot
Notable Players
Population
~4.5MM
Medicinal Legalization
N/A
First Adult-Use Sale
N/A
MMJ Patients
N/A
Monthly Revenue
N/A
Cultivation Licenses
N/A
Retail Licenses
N/A
Updated on May 17, 2022
OH
Ohio Snapshot
Notable Players
Population
~11.7MM
Medicinal Legalization
2016
First Adult-Use Sale
N/A
MMJ Patients
~242K
Monthly Revenue
~$37MM
Cultivation Licenses
29/35 (Operational/Limit)
Retail Licenses
58/130 (Operational/Limit)
Updated on May 17, 2022
MI
Michigan Snapshot
Notable Players
Population
~10MM
Medicinal Legalization
2008
First Adult-Use Sale
2019
MMJ Patients
~250K
Monthly Revenue
~$154MM
Cultivation Licenses
480/No Limit (Operational/Limit)
Retail Licenses
500/ No Limit (Operational/Limit)
Updated on May 17, 2022
IL
Illinois Snapshot
Notable Players
Population
~12.6MM
Medicinal Legalization
2013
First Adult-Use Sale
2020
MMJ Patients
~158K
Monthly Revenue
~$150MM
Cultivation Licenses
61/61 (Operational/Limit)
Retail Licenses
107/107 (Operational/Limit)
Updated on May 17, 2022
WI
Wisconsin Snapshot
Notable Players
Population
~5.86MM
Medicinal Legalization
N/A
First Adult-Use Sale
N/A
MMJ Patients
N/A
Monthly Revenue
N/A
Cultivation Licenses
N/A
Retail Licenses
N/A
Updated on May 17, 2022
LA
Louisiana Snapshot
Notable Players
Population
~4.6MM
Medicinal Legalization
2016
First Adult-Use Sale
N/A
MMJ Patients
~29K
Monthly Revenue
~$2.3MM
Cultivation Licenses
2/2 (Operational/Limit)
Retail Licenses
9/10 (Operational/ Limit)
Updated on May 17, 2022
AR
Arkansas Snapshot
Notable Players
Population
~3MM
Medicinal Legalization
2016
First Adult-Use Sale
N/A
MMJ Patients
~97K
Monthly Revenue
~$25MM
Cultivation Licenses
8/16 (Operational/Limit)
Retail Licenses
36/40 (Operational/Limit)
Updated on May 17, 2022
MO
Missouri Snapshot
Notable Players
Population
~6.2MM
Medicinal Legalization
2018
First Adult-Use Sale
N/A
MMJ Patients
~174K
Monthly Revenue
~$25MM
Cultivation Licenses
39/60 (Operational/Limit)
Retail Licenses
190/192 (Operational/Limit)
Updated on May 17, 2022
IA
Iowa Snapshot
Notable Players
Population
~3.2MM
Medicinal Legalization
2017
First Adult-Use Sale
N/A
MMJ Patients
~8K
Monthly Revenue
~$500K
Cultivation Licenses
1/2 (Operational/Limit)
Retail Licenses
5/5 (Operational/Limit)
Updated on May 17, 2022
MN
Minnesota Snapshot
Notable Players
Population
~5.7MM
Medicinal Legalization
2014
First Adult-Use Sale
N/A
MMJ Patients
~44K
Monthly Revenue
~$6MM
Cultivation Licenses
6/6 (Operational/Limit)*
Retail Licenses
13/13 (Operational/Limit)*
Updated on May 17, 2022
HI
Hawaii Snapshot
Notable Players
Population
~1.4MM
Medicinal Legalization
2000
First Adult-Use Sale
N/A
MMJ Patients
~35K
Monthly Revenue
~$5MM
Cultivation Licenses
8/8 (Operational/Limit)*
Retail Licenses
16/16 (Operational/Limit)*
Updated on May 17, 2022
AK
Alaska Snapshot
Notable Players
Population
~0.7MM
Medicinal Legalization
1998
First Adult-Use Sale
2016
MMJ Patients
440
Monthly Revenue
~$20MM
Cultivation Licenses
267/No Limit (Operational/Limit)
Retail Licenses
161/No Limit (Operational/Limit)
Updated on May 17, 2022
ND
North Dakota Snapshot
Notable Players
Population
~0.8MM
Medicinal Legalization
2016
First Adult-Use Sale
N/A
MMJ Patients
~7K
Monthly Revenue
~$1MM
Cultivation Licenses
2/2 (Operational/Limit)
Retail Licenses
8/8 (Operational/Limit)
Updated on May 17, 2022
SD
South Dakota Snapshot
Notable Players
Population
~0.9MM
Medicinal Legalization
2020
First Adult-Use Sale
Pending
MMJ Patients
500
Monthly Revenue
0
Cultivation Licenses
18/No Limit (Operational/ Limit)
Retail Licenses
39/No Limit (Operational/ Limit)
Updated on May 17, 2022
KS
Kansas Snapshot
Notable Players
Population
~2.9MM
Medicinal Legalization
N/A
First Adult-Use Sale
N/A
MMJ Patients
N/A
Monthly Revenue
N/A
Cultivation Licenses
N/A
Retail Licenses
N/A
Updated on May 17, 2022
OK
Oklahoma Snapshot
Notable Players
Population
~4MM
Medicinal Legalization
2018
First Adult-Use Sale
N/A
MMJ Patients
~400K
Monthly Revenue
~$90MM
Cultivation Licenses
7,953/No Limit (Operational/Limit)
Retail Licenses
2,297/No Limit (Operational/Limit)
Updated on May 17, 2022
TX
Texas Snapshot
Notable Players
Population
~29.7MM
Medicinal Legalization
2015
First Adult-Use Sale
N/A
MMJ Patients
~6K
Monthly Revenue
Negligible
Cultivation Licenses
3/3 (Operational/Limit)
Retail Licenses
3/3 (Operational/Limit)
Updated on May 17, 2022
NM
New Mexico Snapshot
Notable Players
Population
~2.1MM
Medicinal Legalization
2007
First Adult-Use Sale
2022
MMJ Patients
~129K
Monthly Revenue
~$23MM
Cultivation Licenses
104/No Limit (Operational/Limit)*
Retail Licenses
224/No Limit (Operational/Limit)*
Updated on May 17, 2022
CO
Colorado Snapshot
Notable Players
Population
~5.9MM
Medicinal Legalization
2000
First Adult-Use Sale
2014
MMJ Patients
~88K
Monthly Revenue
~$150MM
Cultivation Licenses
1,220/No Limit (Operational/Limit)
Retail Licenses
721/No Limit (Operational/Limit)
Updated on May 17, 2022
MT
Montana Snapshot
Notable Players
Population
~1.1MM
Medicinal Legalization
2004
First Adult-Use Sale
2022
MMJ Patients
~42K
Monthly Revenue
~$22.6MM
Cultivation Licenses
415/No Limit (Operational/Limit)
Retail Licenses
378/No Limit (Operational/Limit)
Updated on May 17, 2022
NV
Nevada Snapshot
Notable Players
Population
~3.1MM
Medicinal Legalization
2000
First Adult-Use Sale
2017
MMJ Patients
~14K
Monthly Revenue
~$80MM
Cultivation Licenses
163/No Limit (Operational/Limit)
Retail Licenses
98/132 (Operational/Limit)
Updated on May 17, 2022
UT
Utah Snapshot
Notable Players
Population
~3.3MM
Medicinal Legalization
2018
First Adult-Use Sale
N/A
MMJ Patients
~53K
Monthly Revenue
~$6MM
Cultivation Licenses
8/10 (Operational/Limit)
Retail Licenses
14/15 (Operational/Limit)
Updated on May 17, 2022
AZ
Arizona Snapshot
Notable Players
Population
~7.3MM
Medicinal Legalization
2010
First Adult-Use Sale
2021
MMJ Patients
~313K
Monthly Revenue
~$115MM
Cultivation Licenses
101/169 (Operational/Limit)
Retail Licenses
130/169 (Operational/Limit)
Updated on May 17, 2022
CA
California Snapshot
Notable Players
Population
~39.5MM
Medicinal Legalization
1996
First Adult-Use Sale
2018
MMJ Patients
~1.9MM
Monthly Revenue
~$443MM
Cultivation Licenses
3,725/No Limit (Operational/Limit)
Retail Licenses
930/No Limit (Operational/Limit)
Updated on May 17, 2022
OR
Oregon Snapshot
Notable Players
Population
~4.2MM
Medicinal Legalization
1998
First Adult-Use Sale
2015
MMJ Patients
~23K
Monthly Revenue
~$100MM
Cultivation Licenses
1,386/No Limit (Operational/Limit)
Retail Licenses
768/No Limit (Operational/Limit)
Updated on May 17, 2022
WA
Washington Snapshot
Notable Players
Population
~7.8MM
Medicinal Legalization
1998
First Adult-Use Sale
2014
MMJ Patients
~54K
Monthly Revenue
~$133MM
Cultivation Licenses
1,062/No Limit (Operational/Limit)
Retail Licenses
479/556 (Operational/Limit)
Updated on May 17, 2022
WA
.svg){kind=small}
Market Research
Top MSO's
Year Passed
1999
Year Passed
1999
Year Passed
1999
Year Passed
1999
Year Passed
1999
Year Passed
1999
Updated on 10/20/20
Blinking indicates recent activity
-States that are not clickable have no meaningful activity.
DC
District of Colombia Market Research
Notable Players
Population
~0.7MM
Medicinal Legalization
1998
First Adult-Use Sale
Pending
MMJ Patients
11K
Monthly Revenue
~$5MM
Cultivation Licenses
8/10 (Operational/Limit)
Retail Licenses
7/8 (Operational/Limit)
Updated on May 17, 2022
ME
Maine Market Research
Notable Players
Population
~1.4MM
Medicinal Legalization
1999
First Adult-Use Sale
2020
MMJ Patients
~77K
Monthly Revenue
~$11MM
Cultivation Licenses
67/No Limit (Operational/Limit)
Retail Licenses
85/No Limit (Operational/Limit)
Updated on May 16, 2022
VT
Vermont Market Research
Notable Players
Population
~0.7MM
Medicinal Legalization
2004
First Adult-Use Sale
Pending
MMJ Patients
~6K
Monthly Revenue
~$2MM
Cultivation Licenses
5/No Limit (Operational/Limit)*
Retail Licenses
6/No Limit (Operational/Limit)*
Updated on May 17, 2022
MA
Massachusetts Market Research
Notable Players
Population
~6.9MM
Medicinal Legalization
2012
First Adult-Use Sale
2018
MMJ Patients
~100K
Monthly Revenue
~$154MM
Cultivation Licenses
121/No Limit (Operational/Limit)
Retail Licenses
222/No Limit (Operational/Limit)
Updated on May 16, 2022
CT
Connecticut Market Research
Notable Players
Population
~3.6MM
Medicinal Legalization
2012
First Adult-Use Sale
Pending
MMJ Patients
~60K
Monthly Revenue
~$15MM
Cultivation Licenses
4/10 (Operational/Limit)
Retail Licenses
17/18 (Operational/Limit)
Updated on May 17, 2022
NY
New York Market Research
Notable Players
Population
~19.4MM
Medicinal Legalization
2014
First Adult-Use Sale
Pending
MMJ Patients
~151K
Monthly Revenue
~$23MM
Cultivation Licenses
11/11 (Operational/Limit)*
Retail Licenses
38/38 (Operational/Limit)*
Updated on May 17, 2022
NJ
New Jersey Market Research
Notable Players
Population
~8.9MM
Medicinal Legalization
2010
First Adult-Use Sale
Pending
MMJ Patients
~125K
Monthly Revenue
~$20MM
Cultivation Licenses
44/37 (Operational/Limit)*
Retail Licenses
24/53 (Operational/Limit)*
Updated on May 17, 2022
VA
Virginia Market Research
Notable Players
Population
~8.6MM
Medicinal Legalization
2018
First Adult-Use Sale
Pending
MMJ Patients
~34K
Monthly Revenue
~$2MM
Cultivation Licenses
4/5 (Operational/Limit)*
Retail Licenses
10/30 (Operational/Limit)*
Updated on May 17, 2022
MI
Michigan Market Research
Notable Players
Population
~10MM
Medicinal Legalization
2008
First Adult-Use Sale
2019
MMJ Patients
~250K
Monthly Revenue
~$154MM
Cultivation Licenses
480/No Limit (Operational/Limit)
Retail Licenses
500/ No Limit (Operational/Limit)
Updated on May 17, 2022
IL
Illinois Market Research
Notable Players
Population
~12.6MM
Medicinal Legalization
2013
First Adult-Use Sale
2020
MMJ Patients
~158K
Monthly Revenue
~$150MM
Cultivation Licenses
61/61 (Operational/Limit)
Retail Licenses
107/107 (Operational/Limit)
Updated on May 17, 2022
AK
Alaska Market Research
Notable Players
Population
~0.7MM
Medicinal Legalization
1998
First Adult-Use Sale
2016
MMJ Patients
440
Monthly Revenue
~$20MM
Cultivation Licenses
267/No Limit (Operational/Limit)
Retail Licenses
161/No Limit (Operational/Limit)
Updated on May 17, 2022
NM
New Mexico Market Research
Notable Players
Population
~2.1MM
Medicinal Legalization
2007
First Adult-Use Sale
2022
MMJ Patients
~129K
Monthly Revenue
~$23MM
Cultivation Licenses
104/No Limit (Operational/Limit)*
Retail Licenses
224/No Limit (Operational/Limit)*
Updated on May 17, 2022
CO
Colorado Market Research
Notable Players
Population
~5.9MM
Medicinal Legalization
2000
First Adult-Use Sale
2014
MMJ Patients
~88K
Monthly Revenue
~$150MM
Cultivation Licenses
1,220/No Limit (Operational/Limit)
Retail Licenses
721/No Limit (Operational/Limit)
Updated on May 17, 2022
MT
Montana Market Research
Notable Players
Population
~1.1MM
Medicinal Legalization
2004
First Adult-Use Sale
2022
MMJ Patients
~42K
Monthly Revenue
~$22.6MM
Cultivation Licenses
415/No Limit (Operational/Limit)
Retail Licenses
378/No Limit (Operational/Limit)
Updated on May 17, 2022
NV
Nevada Market Research
Notable Players
Population
~3.1MM
Medicinal Legalization
2000
First Adult-Use Sale
2017
MMJ Patients
~14K
Monthly Revenue
~$80MM
Cultivation Licenses
163/No Limit (Operational/Limit)
Retail Licenses
98/132 (Operational/Limit)
Updated on May 17, 2022
AZ
Arizona Market Research
Notable Players
Population
~7.3MM
Medicinal Legalization
2010
First Adult-Use Sale
2021
MMJ Patients
~313K
Monthly Revenue
~$115MM
Cultivation Licenses
101/169 (Operational/Limit)
Retail Licenses
130/169 (Operational/Limit)
Updated on May 17, 2022
CA
California Market Research
Notable Players
Population
~39.5MM
Medicinal Legalization
1996
First Adult-Use Sale
2018
MMJ Patients
~1.9MM
Monthly Revenue
~$443MM
Cultivation Licenses
3,725/No Limit (Operational/Limit)
Retail Licenses
930/No Limit (Operational/Limit)
Updated on May 17, 2022
OR
Oregon Market Research
Notable Players
Population
~4.2MM
Medicinal Legalization
1998
First Adult-Use Sale
2015
MMJ Patients
~23K
Monthly Revenue
~$100MM
Cultivation Licenses
1,386/No Limit (Operational/Limit)
Retail Licenses
768/No Limit (Operational/Limit)
Updated on May 17, 2022
WA
Washington Market Research
Notable Players
Population
~7.8MM
Medicinal Legalization
1998
First Adult-Use Sale
2014
MMJ Patients
~54K
Monthly Revenue
~$133MM
Cultivation Licenses
1,062/No Limit (Operational/Limit)
Retail Licenses
479/556 (Operational/Limit)
Updated on May 17, 2022
WA
Market Research
Top MSO's
Year Passed
1999
Year Passed
1999
Year Passed
1999
Year Passed
1999
Year Passed
1999
Year Passed
1999
Updated on 10/20/20
Blinking indicates recent activity
-States that are not clickable have no meaningful activity.
NH
New Hampshire Market Research
Notable Players
Population
~1.4MM
Medicinal Legalization
2013
First Adult-Use Sale
N/A
MMJ Patients
~14K
Monthly Revenue
~$3.5MM
Cultivation Licenses
3/4 (Operational/Limit)*
Retail Licenses
7/7 (Operational/Limit)*
Updated on May 17, 2022
RI
Rhode Island Market Research
Notable Players
Population
~1.1MM
Medicinal Legalization
2005
First Adult-Use Sale
N/A
MMJ Patients
~22K
Monthly Revenue
~$6MM
Cultivation Licenses
68/No Limit (Operational/Limit)
Retail Licenses
3/9 (Operational/Limit)
Updated on May 17, 2022
DE
Delaware Market Research
Notable Players
Population
~3.6MM
Medicinal Legalization
2011
First Adult-Use Sale
N/A
MMJ Patients
~20K
Monthly Revenue
~$5MM
Cultivation Licenses
4/No Limit (Operational/Limit)
Retail Licenses
7/No Limit (Operational/Limit)
Updated on May 17, 2022
MD
Maryland Market Research
Notable Players
Population
~6.1MM
Medicinal Legalization
2014
First Adult-Use Sale
N/A
MMJ Patients
~147K
Monthly Revenue
~$46MM
Cultivation Licenses
18/21 (Operational/Limit)
Retail Licenses
97/102 (Operational/Limit)
Updated on May 17, 2022
PA
Pennsylvania Market Research
Notable Players
Population
~12.8MM
Medicinal Legalization
2016
First Adult-Use Sale
N/A
MMJ Patients
~575K
Monthly Revenue
~$133MM
Cultivation Licenses
33/33 (Operational/Limit)
Retail Licenses
157/157 (Operational/Limit)*
Updated on May 17, 2022
WV
West Virginia Market Research
Notable Players
Population
~1.8MM
Medicinal Legalization
2017
First Adult-Use Sale
N/A
MMJ Patients
~6K
Monthly Revenue
~$1MM
Cultivation Licenses
10/10 (Operational/Limit)
Retail Licenses
8/100 (Operational/Limit)
Updated on May 17, 2022
FL
Florida Market Research
Notable Players
Population
~21.9MM
Medicinal Legalization
2014
First Adult-Use Sale
N/A
MMJ Patients
~600K
Monthly Revenue
~$193MM
Cultivation Licenses
22/22 (Operational/Limit)*
Retail Licenses
440/22 (Operational/Limit)*
Updated on May 17, 2022
GA
Georgia Market Research
Notable Players
Population
~10.8MM
Medicinal Legalization
2015
First Adult-Use Sale
N/A
MMJ Patients
~15K
Monthly Revenue
0
Cultivation Licenses
0/6 (Operational/Limit)
Retail Licenses
0/30 (Operational/Limit)
Updated on May 17, 2022
MS
Mississippi Market Research
Notable Players
Population
~3MM
Medicinal Legalization
N/A
First Adult-Use Sale
N/A
MMJ Patients
0
Monthly Revenue
0
Cultivation Licenses
0 (Operational/Limit)
Retail Licenses
0 (Operational/Limit)
Updated on May 17, 2022
AL
Alabama Market Research
Notable Players
Population
~5.03MM
Medicinal Legalization
2021
First Adult-Use Sale
N/A
MMJ Patients
N/A
Monthly Revenue
N/A
Cultivation Licenses
0/4 (Operational/Limit)
Retail Licenses
0/4 (Operational/Limit)
Updated on May 17, 2022
OH
Ohio Market Research
Notable Players
Population
~11.7MM
Medicinal Legalization
2016
First Adult-Use Sale
N/A
MMJ Patients
~242K
Monthly Revenue
~$37MM
Cultivation Licenses
29/35 (Operational/Limit)
Retail Licenses
58/130 (Operational/Limit)
Updated on May 17, 2022
LA
Louisiana Market Research
Notable Players
Population
~4.6MM
Medicinal Legalization
2016
First Adult-Use Sale
N/A
MMJ Patients
~29K
Monthly Revenue
~$2.3MM
Cultivation Licenses
2/2 (Operational/Limit)
Retail Licenses
9/10 (Operational/ Limit)
Updated on May 17, 2022
AR
Arkansas Market Research
Notable Players
Population
~3MM
Medicinal Legalization
2016
First Adult-Use Sale
N/A
MMJ Patients
~97K
Monthly Revenue
~$25MM
Cultivation Licenses
8/16 (Operational/Limit)
Retail Licenses
36/40 (Operational/Limit)
Updated on May 17, 2022
MO
Missouri Market Research
Notable Players
Population
~6.2MM
Medicinal Legalization
2018
First Adult-Use Sale
N/A
MMJ Patients
~174K
Monthly Revenue
~$25MM
Cultivation Licenses
39/60 (Operational/Limit)
Retail Licenses
190/192 (Operational/Limit)
Updated on May 17, 2022
IA
Iowa Market Research
Notable Players
Population
~3.2MM
Medicinal Legalization
2017
First Adult-Use Sale
N/A
MMJ Patients
~8K
Monthly Revenue
~$500K
Cultivation Licenses
1/2 (Operational/Limit)
Retail Licenses
5/5 (Operational/Limit)
Updated on May 17, 2022
MN
Minnesota Market Research
Notable Players
Population
~5.7MM
Medicinal Legalization
2014
First Adult-Use Sale
N/A
MMJ Patients
~44K
Monthly Revenue
~$6MM
Cultivation Licenses
6/6 (Operational/Limit)*
Retail Licenses
13/13 (Operational/Limit)*
Updated on May 17, 2022
HI
Hawaii Market Research
Notable Players
Population
~1.4MM
Medicinal Legalization
2000
First Adult-Use Sale
N/A
MMJ Patients
~35K
Monthly Revenue
~$5MM
Cultivation Licenses
8/8 (Operational/Limit)*
Retail Licenses
16/16 (Operational/Limit)*
Updated on May 17, 2022
ND
North Dakota Market Research
Notable Players
Population
~0.8MM
Medicinal Legalization
2016
First Adult-Use Sale
N/A
MMJ Patients
~7K
Monthly Revenue
~$1MM
Cultivation Licenses
2/2 (Operational/Limit)
Retail Licenses
8/8 (Operational/Limit)
Updated on May 17, 2022
SD
South Dakota Market Research
Notable Players
Population
~0.9MM
Medicinal Legalization
2020
First Adult-Use Sale
Pending
MMJ Patients
500
Monthly Revenue
0
Cultivation Licenses
18/No Limit (Operational/ Limit)
Retail Licenses
39/No Limit (Operational/ Limit)
Updated on May 17, 2022
OK
Oklahoma Market Research
Notable Players
Population
~4MM
Medicinal Legalization
2018
First Adult-Use Sale
N/A
MMJ Patients
~400K
Monthly Revenue
~$90MM
Cultivation Licenses
7,953/No Limit (Operational/Limit)
Retail Licenses
2,297/No Limit (Operational/Limit)
Updated on May 17, 2022
UT
Utah Market Research
Notable Players
Population
~3.3MM
Medicinal Legalization
2018
First Adult-Use Sale
N/A
MMJ Patients
~53K
Monthly Revenue
~$6MM
Cultivation Licenses
8/10 (Operational/Limit)
Retail Licenses
14/15 (Operational/Limit)
Updated on May 17, 2022
WA
Market Research
Top MSO's
Year Passed
1999
Year Passed
1999
Year Passed
1999
Year Passed
1999
Year Passed
1999
Year Passed
1999
Updated on 10/20/20
Blinking indicates recent activity
-States that are not clickable have no meaningful activity.
NC
North Carolina Market Research
Notable Players
Population
~10.5MM
Medicinal Legalization
First Adult-Use Sale
MMJ Patients
N/A
Monthly Revenue
N/A
Cultivation Licenses
N/A
Retail Licenses
N/A
Updated on May 17, 2022
SC
South Carolina Market Research
Notable Players
Population
~5MM
Medicinal Legalization
First Adult-Use Sale
MMJ Patients
N/A
Monthly Revenue
N/A
Cultivation Licenses
N/A
Retail Licenses
N/A
Updated on May 17, 2022
KY
Kentucky Market Research
Notable Players
Population
~4.5MM
Medicinal Legalization
First Adult-Use Sale
MMJ Patients
N/A
Monthly Revenue
N/A
Cultivation Licenses
N/A
Retail Licenses
N/A
Updated on May 17, 2022
WI
Wisconsin Market Research
Notable Players
Population
~5.86MM
Medicinal Legalization
First Adult-Use Sale
MMJ Patients
N/A
Monthly Revenue
N/A
Cultivation Licenses
N/A
Retail Licenses
N/A
Updated on May 17, 2022
KS
Kansas Market Research
Notable Players
Population
~2.9MM
Medicinal Legalization
First Adult-Use Sale
MMJ Patients
N/A
Monthly Revenue
N/A
Cultivation Licenses
N/A
Retail Licenses
N/A
Updated on May 17, 2022
TX
Texas Market Research
Notable Players
Population
~29.7MM
Medicinal Legalization
2015
First Adult-Use Sale
MMJ Patients
~6K
Monthly Revenue
Negligible
Cultivation Licenses
3/3 (Operational/Limit)
Retail Licenses
3/3 (Operational/Limit)
Updated on May 17, 2022
WA
Market Research
Top MSO's
Year Passed
1999
Year Passed
1999
Year Passed
1999
Year Passed
1999
Year Passed
1999
Year Passed
1999
Updated on 10/20/20
Blinking indicates recent activity
-States that are not clickable have no meaningful activity.
No items found.
WA
Market Research
Top MSO's
Year Passed
1999
Year Passed
1999
Year Passed
1999
Year Passed
1999
Year Passed
1999
Year Passed
1999
Updated on 10/20/20
connect with us
